To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration ...
Drug delivery devices are in the safety regulation crosshairs as of late, as a growing list of the technologies have found themselves the subject of recalls and corrections in recent weeks. Latest to ...
The FDA announced May 30 that OptumHealth Care Solutions is recalling 208 infusion pump systems. The product, called the Optum Nimbus II Plus Ambulatory Infusion System — sometimes called the Nimbus ...
Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson (BDX.N), opens new tab is recalling its Alaris infusion pumps due to compatibility issues with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results